Loading company…
Metri Bio develops therapeutics for endometrial diseases, including endometriosis.
Metri Bio is developing therapeutics intended to address endometriosis and other endometrial diseases through research into disease mechanisms and treatment targets. It works with healthcare providers, researchers and patients. Based in Boston, US, the company raised USD 5 million in pre-seed funding in December 2025, led by Pillar with Pace Ventures Enigma, Slocum Management and Navec Investments participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in